Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

347 ARTíCULOS , VIENDO DEL 46 AL 60

PUBMED

Diabetic chorea as a neurological complication.

Kenzaka T, Fujikawa M, Matsumoto M.

Clin Case Rep. 2018 May 15;6(7):1398-1399. doi: 10.1002/ccr3.1579. eCollection 2018 Jul.

0

0

0

PUBMED

Are immunotherapies for Huntington's disease a realistic option?

Denis HL, Lauruol F, Cicchetti F.

Mol Psychiatry. 2018 Feb 27. doi: 10.1038/s41380-018-0021-9. [Epub ahead of print] Review.

0

0

0

PUBMED

Functional Magnetic Resonance Imaging in Huntington's Disease.

Gregory S, Scahill RI.

Int Rev Neurobiol. 2018;142:381-408. doi: 10.1016/bs.irn.2018.09.013. Epub 2018 Oct 29.

0

0

0

PUBMED

Pathophysiology in the suprachiasmatic nucleus in mouse models of Huntington's disease.

Kuljis D, Kudo T, Tahara Y, Ghiani CA, Colwell CS.

J Neurosci Res. 2018 Aug 31. doi: 10.1002/jnr.24320. [Epub ahead of print]

0

0

0

PUBMED

Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood-brain barrier integrity and exerts therapeutic effect in an animal model of Huntington's disease.

Di Pardo A, Castaldo S, Amico E, Pepe G, Marracino F, Capocci L, Giovannelli A, Madonna M, van Bergeijk J, Buttari F, van der Kam E, Maglione V.

Hum Mol Genet. 2018 Jul 15;27(14):2490-2501. doi: 10.1093/hmg/ddy153.

0

0

0

PUBMED

Environment-dependent striatal gene expression in the BACHD rat model for Huntington disease.

Novati A, Hentrich T, Wassouf Z, Weber JJ, Yu-Taeger L, Déglon N, Nguyen HP, Schulze-Hentrich JM.

Sci Rep. 2018 Apr 11;8(1):5803. doi: 10.1038/s41598-018-24243-z.

0

0

0

PUBMED

Clinical Features of Huntington's Disease.

Ghosh R, Tabrizi SJ.

Adv Exp Med Biol. 2018;1049:1-28. doi: 10.1007/978-3-319-71779-1_1.

0

0

0

PUBMED

Evaluation of Cognition and Cortical Excitability in Huntington's Disease.

Kamble N, Netravathi M, Nagaraju BC, Lenka A, Kumar K, Sowmya V, Jain S, Pal PK.

Can J Neurol Sci. 2018 Jan 8:1-6. doi: 10.1017/cjn.2017.277. [Epub ahead of print]

0

0

0

PUBMED

Chorea-Acanthocytosis in a Chinese Family With a Pseudo-Dominant Inheritance Mode.

Yi F, Li W, Xie N, Zhou Y, Xu H, Sun Q, Zhou L.

Front Neurol. 2018 Jul 24;9:594. doi: 10.3389/fneur.2018.00594. eCollection 2018.

0

0

0

PUBMED

A Patient-Derived Cellular Model for Huntington's Disease Reveals Phenotypes at Clinically Relevant CAG Lengths.

Hung CL, Maiuri T, Bowie LE, Gotesman R, Son S, Falcone M, Giordano JV, Gillis T, Mattis V, Lau T, Kwan V, Wheeler V, Schertzer J, Singh K, Truant R.

Mol Biol Cell. 2018 Sep 26:mbcE18090590. doi: 10.1091/mbc.E18-09-0590. [Epub ahead of print]

0

0

0

PUBMED

Early Detection of Apathetic Phenotypes in Huntington's Disease Knock-in Mice Using Open Source Tools.

Minnig S, Bragg RM, Tiwana HS, Solem WT, Hovander WS, Vik ES, Hamilton M, Legg SRW, Shuttleworth DD, Coffey SR, Cantle JP, Carroll JB.

Sci Rep. 2018 Feb 2;8(1):2304. doi: 10.1038/s41598-018-20607-7.

0

0

0

PUBMED

Inhibition of TRPC1-Dependent Store-Operated Calcium Entry Improves Synaptic Stability and Motor Performance in a Mouse Model of Huntington's Disease.

Wu J, Ryskamp D, Birnbaumer L, Bezprozvanny I.

J Huntingtons Dis. 2018;7(1):35-50. doi: 10.3233/JHD-170266.

0

0

0

PUBMED

New pathogenic mutation of chorea-acanthocytosis.

Garrido-Fernández A, Santos-Lasaosa S, Bellosta-Diago E, Sáchez-Valiente S.

Neurologia. 2018 May 8. pii: S0213-4853(18)30099-9. doi: 10.1016/j.nrl.2018.03.012. [Epub ahead of print] English, Spanish. No abstract available.

0

0

0

PUBMED

Factors contributing to clinical picture and progression of Huntington's disease.

Zielonka D.

Neural Regen Res. 2018 Aug;13(8):1364-1365. doi: 10.4103/1673-5374.235241. No abstract available.

0

0

0

PUBMED

Chorea, psychosis, acanthocytosis, and prolonged survival associated with ELAC2 mutations.

Paucar M, Pajak A, Freyer C, Bergendal Å, Döry M, Laffita-Mesa JM, Stranneheim H, Lagerstedt-Robinson K, Savitcheva I, Walker RH, Wedell A, Wredenberg A, Svenningsson P.

Neurology. 2018 Sep 14. pii: 10.1212/WNL.0000000000006320. doi: 10.1212/WNL.0000000000006320. [Epub ahead of print] No abstract available.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy